InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Innovative Cellular Therapeutics Holdings Ltd. Officer active across 1 company, notably Lyell Immunopharma, Inc.. Cumulatively, 4 reports have been recorded. Split: 0 buy · 2 sells. Total volume traded: €239. Activity tracked since 16 July 2026. The latest transaction was disclosed on 27 July 2026 (J). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations